Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

House, Senate Committees Release Draft Health Care Reform Proposals
Democratic leaders in the House and Senate on Tuesday released draft versions of health care reform legislation in their respective chambers that outline several initiatives, including a public health insurance option that has been the focus of debate between Democratic leaders who favor it and Republicans and moderate Democrats who oppose the provision, The Hill reports (Soraghan, The Hill, 6/9). According to the New York Times, the draft bills represent an emerging consensus between the Senate and House on how to move forward with health reform (Pear, New York Times, 6/10).The Senate Health, Education, Labor and Pensions Committee"s 615-page draft health care bill would expand eligibility for Medicaid and allow families with incomes up to 500% of the federal poverty level to qualify for subsidies to purchase insurance. In addition, the bill includes an individual mandate requiring U.S. residents to purchase insurance, reforms for the insurance market, suspension of coverage denials based on pre-existing conditions and the establishment of a health insurance exchange where U.S. residents can compare and buy coverage (Budoff Brown, Politico, 6/9). Sen. Christopher Dodd (D-Conn.), the second-ranking Democrat on the HELP Committee, will lead mark-up sessions scheduled to begin June 16 while Committee Chair Edward Kennedy (D-Mass.) undergoes treatment for brain cancer (The Hill, 6/9). At a meeting of the House Democratic Caucus, the leaders of the three House committees charged with crafting health reform legislation outlined a bill with similar provisions to the one being written in the Senate (New York Times, 6/10). The bill -- which is being drafted by the chairs of the House Ways and Means, Energy and Commerce, and Education and Labor committees -- calls for a public plan, an individual mandate, a mandate for employers to help pay for coverage and the creation of a health insurance exchange. Under the House bill, families with incomes up to 400% of the federal poverty level would qualify for subsidies for insurance. The House bill also would expand Medicaid by determining eligibility entirely on income, according to a House aide. Currently, many Medicaid applicants must meet other criteria, such as being a parent, in addition to having a low income, to qualify. The House is expected to release a formal version of the bill next week.Both draft bills released on Tuesday did not include details on how the proposals would be financed. According to the Wall Street Journal the omission gives lawmakers time to better assess the costs involved and promote health reform to the public (Bendavid/Adamy, Wall Street Journal, 6/10).
generic viagra online
Lawsuits Allege Some Medical Device Companies Gave Kickbacks To Surgeons
Whistleblowers allege in lawsuits unsealed Wednesday that some medical device companies gave kickbacks to heart surgeons to get the doctors to use their products to treat a heart condition, The Wall Street Journal reports.
News of the day
Strategies Evolving As Retractable Safety Syringe Suppliers Strive For Traction
Following the lead of the Needlestick Safety and Prevention Act in the U.S., government regulations regarding syringe needle handling and disposal continue to proliferate worldwide, fostering increased demand in the use of safety syringes. Retractable syringes represent the most elegant approach to addressing the caregiver sharps risk issue by lowering the risk of user error and de-emphasizing the need for a separate sharps disposal step.
Cardiovascular

Cannabis Science Receives FDA Industry Guidelines For Mapping Out Its Initial Drugs Offerings For FDA Submission And Testing

Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to report that the FDA has provided the Company with documentation to assist the Company to review and plan its initial applications to get its first drug into formal testing. Cannabis Science, Inc. President & CEO Dr. Robert Melamede stated, "After speaking directly with the FDA discussing our products and initiatives I was pleasantly surprised with the hands on approach they have with helping us map our path to get our products into testing. We have a ways to go, but I am very optimistic that we have an opportunity to have more than one product in testing and trials at the same time. We have an exciting new initiative we plan to announce shortly and I would like to thank our current and future shareholders for helping to make this happen." Cannabis Science H1N1 Swine Flu Formulation We now know that the endocannabinoid system plays a critical role in maintaining human health. The human body produces Endocannabinoids on demand when they are needed. They help restore homeostasis (biochemical balance). The Cannabis plant produces Phytocannabinoids. When the human body has endocannabinoid deficiencies, it cannot effectively restore the healthy biochemical state needed to counter a particular illness. Phytocannabinoids from the Cannabis plant can replace the deficient endocannabinoid activity in the human body to restore a health-promoting level of cannabinoid activity. Cannabis Science will test its cannabis extract lozenge with FDA guidance and oversight to determine if it will reduce ARDS-associated deaths from both the Avian and Swine influenza infections. H1N1 Swine Flu According to the CDC (http://www.cdc.gov/flu/avian/) the Avian flu (H5N1) has a 63% mortality rate. Unfortunately, the Swine flu, while causing death at a much lower rate than the Avian flu, appears to also result in death via a similar mechanism. The common cause of death with these strains is organ failure, especially as seen in the lungs with the development of Adult Respiratory Distress Syndrome (ARDS). ARDS is caused by an excess immune-generated inflammatory response that leads to apoptosis (cell death) and subsequently to organ failure. The Company"s approach will mimic how the human body uses endocannabinoids (cannabinoids that occur naturally in the body) to regulate immune activity and cell survival, by regulating inflammatory biochemistry. Excessive inflammatory responses are associated with numerous disease states including autoimmune diseases, neurological imbalances, and cardiovascular disease. Phytocannabinoids provide a natural means to supplement illness-specific endocannabinoid deficiencies. Cannabis Science, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009